FdaApplication

ANDA 207842

Back to search

Identifiers

Properties

PropertyValue
applicant_nameWESTMINSTER PHARMACEUTICALS LLC
application_typeANDA
approval_date2021-10-25

Products (2)

ProductActive ingredientStrengthDosage form
EPLERENONEEPLERENONE25MGTABLET;ORAL
EPLERENONEEPLERENONE50MGTABLET;ORAL

2 products